3D printed PHB-dextran-whitlockite porous construct coated with sildenafil-loaded nanofibers: a hybrid scaffold for craniofacial reconstruction
Abstract
In this study, a novel hybrid scaffold comprising 3D-printed porous polyhydroxybutyrate (PHB), dextran (Dex), and magnesium-doped whitlockite (WL) nanoparticles was developed, which were further enhanced with an electrospun nanofibrous coating composed of Dex and Pluronic F127 (F127) loaded with Sildenafil (Sil) for use in craniofacial regeneration. This design was intended to improve the solubility of sildenafil and enable controlled release. Scanning electron microscopy (SEM) revealed a well-integrated structure between the 3D-printed strands and electrospun nanofibers. The scaffold exhibited sustained release of Sil over 28 days, with mechanical testing showing a compressive strength of 3.70 ± 0.33 MPa and an elastic modulus of 49.04 ± 4.62 MPa. Non-toxicity was confirmed via MTT assay on the MG63 cell line, and qRT-PCR results indicated significantly higher expression levels of collagen I, RUNX2, osteocalcin, VEGF, and CD31 markers associated with osteogenesis and angiogenesis. Following implantation in a rat calvarial defect model, the scaffold demonstrated robust osteogenic activity and new bone tissue formation over an eight-week period. This innovative scaffold design offers a promising solution for overcoming the challenges in craniofacial defect repair by integrating bioactive materials with advanced drug delivery systems, leading to more effective tissue regeneration strategies.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.